His primary scientific interests are in Biochemistry, Peroxisome, Internal medicine, Endocrinology and Peroxisomal disorder. Many of his studies on Biochemistry apply to Molecular biology as well. His research investigates the connection with Peroxisome and areas like Fatty acid which intersect with concerns in Pristanic acid, Glyoxysome and Metabolism.
His work on Mevalonic aciduria as part of general Internal medicine study is frequently connected to Smith–Lemli–Opitz syndrome, therefore bridging the gap between diverse disciplines of science and establishing a new relationship between them. He has researched Endocrinology in several fields, including Familial Mediterranean fever, 7-Dehydrocholesterol reductase and Docosapentaenoic acid. His Peroxisomal disorder study integrates concerns from other disciplines, such as Pathology, Chromatography and Refsum disease, Phytanic acid.
Biochemistry, Peroxisome, Internal medicine, Endocrinology and Peroxisomal disorder are his primary areas of study. His Enzyme, Fatty acid, Mitochondrion, Pristanic acid and Alpha oxidation investigations are all subjects of Biochemistry research. His research on Peroxisome often connects related topics like Pipecolic acid.
His work carried out in the field of Internal medicine brings together such families of science as Mutation and Pathology. His study ties his expertise on Human genetics together with the subject of Endocrinology. His study of Rhizomelic chondrodysplasia punctata is a part of Peroxisomal disorder.
His scientific interests lie mostly in Biochemistry, Internal medicine, Endocrinology, Peroxisome and Carnitine. All of his Biochemistry and Fatty acid, Phytanic acid, Refsum disease, Mitochondrion and Beta oxidation investigations are sub-components of the entire Biochemistry study. His studies deal with areas such as Dehydrogenase, Genotype, Mutation and Pathology as well as Internal medicine.
His Endocrinology research includes themes of Enzyme assay, Enzyme, Newborn screening, Myopathy and Acyl CoA dehydrogenase. His study in Peroxisome concentrates on Pristanic acid and Peroxisomal disorder. The study incorporates disciplines such as Transporter and Primary Carnitine Deficiency in addition to Carnitine.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Quantification of the contribution of various steps to the control of mitochondrial respiration.
A K Groen;R J Wanders;H V Westerhoff;R van der Meer.
Journal of Biological Chemistry (1982)
Peroxisomal disorders: a newly recognised group of genetic diseases.
R. B. H. Schutgens;H. S. A. Heymans;R. J. A. Wanders;H. v. d. Bosch.
European Journal of Pediatrics (1986)
The ABC transporter proteins Pat1 and Pat2 are required for import of long-chain fatty acids into peroxisomes of Saccharomyces cerevisiae.
E. H. Hettema;C. W. T. Van Roermund;B. Distel;M. Van Den Berg.
The EMBO Journal (1996)
The membrane of peroxisomes in Saccharomyces cerevisiae is impermeable to NAD(H) and acetyl-CoA under in vivo conditions.
C. W. T. Van Roermund;Y. Elgersma;Neena Singh;R. J. A. Wanders.
The EMBO Journal (1995)
A new peroxisomal disorder with enlarged peroxisomes and a specific deficiency of acyl-CoA oxidase (pseudo-neonatal adrenoleukodystrophy).
B T Poll-The;F Roels;H Ogier;J Scotto.
American Journal of Human Genetics (1988)
Peroxisomal fatty acid α- and β-oxidation in humans: enzymology, peroxisomal metabolite transporters and peroxisomal diseases
R. J. A. Wanders;P. Vreken;S. Ferdinandusse;G. A. Jansen.
Biochemical Society Transactions (2001)
Control of mitochondrial respiration
J.M. Tager;R.J.A Wanders;A.K. Groen;W. Kunz.
FEBS Letters (1983)
Rhizomelic chondrodysplasia punctata is a peroxisomal protein targeting disease caused by a non-functional PTS2 receptor.
A. M. Motley;E. H. Hettema;E. M. Hogenhout;P. Brites.
Nature Genetics (1997)
Deficiency of acyl-CoA: dihydroxyacetone phosphate acyltransferase in patients with Zellweger (cerebro-hepato-renal) syndrome
R.B.H. Schutgens;G.J. Romeyn;R.J.A. Wanders;H. van den Bosch.
Biochemical and Biophysical Research Communications (1984)
Significantly reduced docosahexaenoic and docosapentaenoic acid concentrations in erythrocyte membranes from schizophrenic patients compared with a carefully matched control group
Johanna Assies;Ritsaert Lieverse;Peter Vreken;Ron J.A Wanders.
Biological Psychiatry (2001)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: